Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Jialu Fang, Guosheng Yin |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Assurance methods for designing a clinical trial with a delayed treatment effect
by: James A. Salsbury, et al.
Published: (2024)
by: James A. Salsbury, et al.
Published: (2024)
Confidence intervals for odds ratio from multistage randomized phase II trials
by: Shiwei Cao, et al.
Published: (2024)
by: Shiwei Cao, et al.
Published: (2024)
Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
by: Yunfei Wang
Published: (2024)
by: Yunfei Wang
Published: (2024)
Group sequential designs for clinical trials when the maximum sample size is uncertain
by: Amin Yarahmadi, et al.
Published: (2024)
by: Amin Yarahmadi, et al.
Published: (2024)
Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
by: Peiran Liu, et al.
Published: (2024)
by: Peiran Liu, et al.
Published: (2024)
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
by: Stephen Schüürhuis, et al.
Published: (2024)
by: Stephen Schüürhuis, et al.
Published: (2024)
Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
by: Wenhao Cao, et al.
Published: (2024)
by: Wenhao Cao, et al.
Published: (2024)
Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
by: Luana Boumendil, et al.
Published: (2024)
by: Luana Boumendil, et al.
Published: (2024)
A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
by: Tianyu Zhan
Published: (2024)
by: Tianyu Zhan
Published: (2024)
Correction to “Using principal stratification in analysis of clinical trials”
by: Ilya Lipkovich, et al.
Published: (2024)
by: Ilya Lipkovich, et al.
Published: (2024)
A sequential, multiple assignment, randomized trial design with a tailoring function
by: Holly Hartman, et al.
Published: (2024)
by: Holly Hartman, et al.
Published: (2024)
Use of win time for ordered composite endpoints in clinical trials
by: James F. Troendle, et al.
Published: (2024)
by: James F. Troendle, et al.
Published: (2024)
Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
by: Xiaosong Shi, et al.
Published: (2024)
by: Xiaosong Shi, et al.
Published: (2024)
Confidence distributions for treatment effects in clinical trials: Posteriors without priors
by: Ian C. Marschner
Published: (2024)
by: Ian C. Marschner
Published: (2024)
Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
by: Shuxi Zeng, et al.
Published: (2024)
by: Shuxi Zeng, et al.
Published: (2024)
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
by: Yu Du, et al.
Published: (2024)
by: Yu Du, et al.
Published: (2024)
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
by: Johannes Krisam, et al.
Published: (2024)
by: Johannes Krisam, et al.
Published: (2024)
Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
by: Edward L. Korn, et al.
Published: (2024)
by: Edward L. Korn, et al.
Published: (2024)
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
by: Jonathan C. Moyer, et al.
Published: (2024)
by: Jonathan C. Moyer, et al.
Published: (2024)
Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
by: Matthias Kormaksson, et al.
Published: (2024)
by: Matthias Kormaksson, et al.
Published: (2024)
Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization
by: Peng Yang, et al.
Published: (2024)
by: Peng Yang, et al.
Published: (2024)
Utilizing local likelihood in regression discontinuity design: Investigating the impact of antiretroviral therapy eligibility on retention in clinical HIV care in South Africa
by: Jaehyun Seo, et al.
Published: (2024)
by: Jaehyun Seo, et al.
Published: (2024)
Nonparametric Estimation of the Potential Impact Fraction and the Population Attributable Fraction With Individual‐Level and Aggregated Data
by: Colleen E. Chan, et al.
Published: (2025)
by: Colleen E. Chan, et al.
Published: (2025)
Beyond the two‐trials rule
by: Leonhard Held
Published: (2024)
by: Leonhard Held
Published: (2024)
Determining sample size in a personalized randomized controlled (PRACTical) trial
by: Rebecca M. Turner, et al.
Published: (2024)
by: Rebecca M. Turner, et al.
Published: (2024)
Robust analysis of stepped wedge trials using composite likelihood models
by: Emily C. Voldal, et al.
Published: (2024)
by: Emily C. Voldal, et al.
Published: (2024)
Modeling intra‐individual inter‐trial EEG response variability in autism
by: Mingfei Dong, et al.
Published: (2024)
by: Mingfei Dong, et al.
Published: (2024)
The Whys, Whens, and Hows of Futility Monitoring
by: Karen M. Higgins, et al.
Published: (2025)
by: Karen M. Higgins, et al.
Published: (2025)
Approximate balancing weights for clustered observational study designs
by: Eli Ben‐Michael, et al.
Published: (2024)
by: Eli Ben‐Michael, et al.
Published: (2024)
Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
by: Carly Lupton Brantner, et al.
Published: (2024)
by: Carly Lupton Brantner, et al.
Published: (2024)
Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
by: Dustin J. Rabideau, et al.
Published: (2024)
by: Dustin J. Rabideau, et al.
Published: (2024)
Time‐varying dynamic Bayesian network learning for an fMRI study of emotion processing
by: Lizhe Sun, et al.
Published: (2024)
by: Lizhe Sun, et al.
Published: (2024)
Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
by: Thomas Burnett, et al.
Published: (2024)
by: Thomas Burnett, et al.
Published: (2024)
A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
by: Samuel K Sarkodie, et al.
Published: (2024)
by: Samuel K Sarkodie, et al.
Published: (2024)
Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers
by: Yanping Chen, et al.
Published: (2024)
by: Yanping Chen, et al.
Published: (2024)
Optimal Linear Combination of Biomarkers by Weighted Youden Index Maximization
by: Sizhe Wang, et al.
Published: (2025)
by: Sizhe Wang, et al.
Published: (2025)
A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study
by: Zoë S. Dunias, et al.
Published: (2024)
by: Zoë S. Dunias, et al.
Published: (2024)
Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?
by: Matthew Dodd, et al.
Published: (2024)
by: Matthew Dodd, et al.
Published: (2024)
Confidence sets for a level set in linear regression
by: Fang Wan, et al.
Published: (2024)
by: Fang Wan, et al.
Published: (2024)
Distribution–free hyperrectangular tolerance regions for setting multivariate reference regions in laboratory medicine
by: Wei Liu, et al.
Published: (2024)
by: Wei Liu, et al.
Published: (2024)
Similar Items
-
Assurance methods for designing a clinical trial with a delayed treatment effect
by: James A. Salsbury, et al.
Published: (2024) -
Confidence intervals for odds ratio from multistage randomized phase II trials
by: Shiwei Cao, et al.
Published: (2024) -
Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
by: Yunfei Wang
Published: (2024) -
Group sequential designs for clinical trials when the maximum sample size is uncertain
by: Amin Yarahmadi, et al.
Published: (2024) -
Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
by: Peiran Liu, et al.
Published: (2024)